Blog
About

  • Record: found
  • Abstract: found
  • Article: found
Is Open Access

Malignant Perivascular Epithelioid Cell Neoplasm of the Mediastinum and the Lung : One Case Report

, MD, , MD, , MD

Medicine

Wolters Kluwer Health

Read this article at

Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      A perivascular epithelioid cell neoplasm (PEComa) in the chest is rare, let alone in the mediastinum and lung.

      A 63-year-old man was admitted to our hospital with chest pain for more than 2 months and was found to have an opacity in his mediastinum and lung for 3 weeks. Enhanced chest computed tomography (CT) revealed a mass in both the left upper lobe and central anterior mediastinum. To identify the disease, a CT-guided percutaneous transthoracic needle biopsy of the upper left lung lesions was performed. The pathology result was consistent with epithelioid angiomyolipoma/PEComa. After a standard preparation for surgery, the neoplasms in the mediastinum and left lung were resected. The operative findings revealed extensive mediastinal tumor invasion in parts adjacent to the pericardium, including the mediastinal pleura, left pulmonary artery and vein, and phrenic nerve. The left lung tumor had invaded the lung membranes. The final pathologic diagnosis was malignant epithelioid angioleiomyoma in the left upper lung and mediastinum. Later, the mediastinal tumor recurred. The radiography of this case resembles left upper lobe lung cancer with mediastinal lymph node metastasis. Because this tumor lacks fat, the enhanced CT indicated that it was malignant but failed to identify it as a perivascular epithelioid cell neoplasm.

      This case reminds clinicians that, although most PEComa are benign, some can be malignant. As the radiology indicated, chest PEComas lack fat, which makes their preoperative diagnosis difficult. Therefore, needle biopsy is valuable for a definitive diagnosis.

      Related collections

      Most cited references 24

      • Record: found
      • Abstract: not found
      • Article: not found

      The tuberous sclerosis complex.

        Bookmark
        • Record: found
        • Abstract: found
        • Article: not found

        Identification and characterization of the tuberous sclerosis gene on chromosome 16.

          (1993)
        Tuberous sclerosis (TSC) is an autosomal dominant multisystem disorder with loci assigned to chromosomes 9 and 16. Using pulsed-field gel electrophoresis (PFGE), we identified five TSC-associated deletions at 16p13.3. These were mapped to a 120 kb region that was cloned in cosmids and from which four genes were isolated. One gene, designated TSC2, was interrupted by all five PFGE deletions, and closer examination revealed several intragenic mutations, including one de novo deletion. In this case, Northern blot analysis identified a shortened transcript, while reduced expression was observed in another TSC family, confirming TSC2 as the chromosome 16 TSC gene. The 5.5 kb TSC2 transcript is widely expressed, and its protein product, tuberin, has a region of homology to the GTPase-activating protein GAP3.
          Bookmark
          • Record: found
          • Abstract: found
          • Article: not found

          Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

          Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the widespread development of distinctive tumors termed hamartomas. TSC-determining loci have been mapped to chromosomes 9q34 (TSC1) and 16p13 (TSC2). The TSC1 gene was identified from a 900-kilobase region containing at least 30 genes. The 8.6-kilobase TSC1 transcript is widely expressed and encodes a protein of 130 kilodaltons (hamartin) that has homology to a putative yeast protein of unknown function. Thirty-two distinct mutations were identified in TSC1, 30 of which were truncating, and a single mutation (2105delAAAG) was seen in six apparently unrelated patients. In one of these six, a somatic mutation in the wild-type allele was found in a TSC-associated renal carcinoma, which suggests that hamartin acts as a tumor suppressor.
            Bookmark

            Author and article information

            Affiliations
            Form the Department of Radiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
            Author notes
            Correspondence: Wenjie Liang, Department of Radiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79# qingchun road, Hangzhou city, Zhejiang province, China 310003;. E-mail: baduen.c@ 123456163.com
            Journal
            Medicine (Baltimore)
            Medicine (Baltimore)
            MEDI
            Medicine
            Wolters Kluwer Health
            0025-7974
            1536-5964
            June 2015
            05 June 2015
            : 94
            : 22
            26039123
            4616358
            10.1097/MD.0000000000000904
            00904
            (Editor)
            Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

            This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0

            Product
            Categories
            6800
            Research Article
            Clinical Case Report
            Custom metadata
            TRUE

            Comments

            Comment on this article